OpenAI acquires Orchestra Bio to accelerate biopharma AI R&D

OpenAI has acquired Orchestra Bio, a life sciences AI operations company. The acquisition aims to bring AI-powered workflows to biopharma teams working on drug development, potentially accelerating treatment discovery timelines.